1h Free Analyst Time
The biomarkers market is forecasted to grow by USD 87.96 billion during 2023-2028, accelerating at a CAGR of 16.83% during the forecast period. The report on the biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of heart diseases, growing advancements in genomics and proteomics, and growing focus on development of biomarker-based diagnostic methods.
The biomarkers market is segmented as below:
By Type
- Safety
- Efficacy
- Validation
By Application
- Drug discovery and development
- Diagnostics
- Personalized medicine
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the biomarkers market covers the following areas:
- Biomarkers market sizing
- Biomarkers market forecast
- Biomarkers market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global biomarkers market: Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BG Medicine Inc., Bio Techne Corp., CENTOGENE NV, Charles River Laboratories International Inc., DiaSorin Spa, EKF Diagnostics Holdings Plc, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., General Electric Co., Merck KGaA, Meso Scale Diagnostics LLC, Nexus Dx Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of research and development programs and new product launches."
According to the report, one of the major drivers for this market is the increasing prevalence of heart diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam plc
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- BG Medicine Inc.
- Bio Techne Corp.
- CENTOGENE NV
- Charles River Laboratories International Inc.
- DiaSorin Spa
- EKF Diagnostics Holdings Plc
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- General Electric Co.
- Merck KGaA
- Meso Scale Diagnostics LLC
- Nexus Dx Inc.
- QIAGEN NV
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
